Header Logo

Connection

MEHMET OKCU to Humans

Back to Details
This is a "connection" page, showing publications MEHMET OKCU has written about Humans.
MEHMET OKCU
Connection Strength
0.795
Humans
  1. Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer. 2025 Mar; 72(3):e31477.
    View in: PubMed
    Score: 0.026
  2. Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy. Pediatr Blood Cancer. 2024 Apr; 71(4):e30873.
    View in: PubMed
    Score: 0.024
  3. Response to Letter to the Editor: Low-Dose Dextrose Prolotherapy as Effective as High-Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis? A Double-Blind, Ultrasound Guided, Randomized Controlled Study. Arch Phys Med Rehabil. 2023 07; 104(7):1155-1156.
    View in: PubMed
    Score: 0.023
  4. Is Low-Dose Dextrose Prolotherapy as Effective as High-Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis? A Double-Blind, Ultrasound Guided, Randomized Controlled Study. Arch Phys Med Rehabil. 2023 02; 104(2):179-187.
    View in: PubMed
    Score: 0.022
  5. A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child. Pediatr Blood Cancer. 2023 03; 70(3):e29972.
    View in: PubMed
    Score: 0.022
  6. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 08 01; 44(6):305-312.
    View in: PubMed
    Score: 0.021
  7. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.020
  8. Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors Turk J Haematol. 2019 02 07; 36(1):1-11.
    View in: PubMed
    Score: 0.017
  9. Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature. J Neurooncol. 2017 Oct; 135(1):213-215.
    View in: PubMed
    Score: 0.015
  10. Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma? Pediatr Blood Cancer. 2016 Feb; 63(2):202-5.
    View in: PubMed
    Score: 0.014
  11. Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications. Pediatr Blood Cancer. 2015 Nov; 62(11):1925-8.
    View in: PubMed
    Score: 0.013
  12. Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014 Jun; 61(6):970-6.
    View in: PubMed
    Score: 0.012
  13. Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma. Pediatr Blood Cancer. 2013 Apr; 60(4):593-8.
    View in: PubMed
    Score: 0.011
  14. Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer. 2011 Sep; 57(3):454-60.
    View in: PubMed
    Score: 0.010
  15. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2012 Apr; 58(4):513-8.
    View in: PubMed
    Score: 0.010
  16. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.010
  17. Comparison of birth weight corrected for gestational age and birth weight alone in prediction of development of childhood leukemia and central nervous system tumors. Pediatr Blood Cancer. 2010 Feb; 54(2):242-9.
    View in: PubMed
    Score: 0.009
  18. Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol. 2009 Jun; 11(3):292-300.
    View in: PubMed
    Score: 0.008
  19. Rhabdomyosarcoma. Curr Probl Cancer. 2008 Jan-Feb; 32(1):7-34.
    View in: PubMed
    Score: 0.008
  20. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008 Jan; 152(1):101-5.
    View in: PubMed
    Score: 0.008
  21. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow. Pediatr Blood Cancer. 2005 Nov; 45(6):787-95.
    View in: PubMed
    Score: 0.007
  22. Could the Hanging Drop Technique Be an Alternative Method to Loss of Resistance in Cervical Epidural Injections? Pain Physician. 2025 May; 28(3):217-221.
    View in: PubMed
    Score: 0.007
  23. Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
    View in: PubMed
    Score: 0.007
  24. Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients-A Single Center Study. Pediatr Blood Cancer. 2025 Feb; 72(2):e31451.
    View in: PubMed
    Score: 0.006
  25. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.006
  26. The impact of margins and re-resection in pediatric synovial sarcoma. Cancer Med. 2024 Sep; 13(17):e70207.
    View in: PubMed
    Score: 0.006
  27. Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department. Pediatr Blood Cancer. 2024 Oct; 71(10):e31222.
    View in: PubMed
    Score: 0.006
  28. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004 Apr 15; 10(8):2618-25.
    View in: PubMed
    Score: 0.006
  29. Adaptive, behavioral, and emotional outcomes following postoperative pediatric cerebellar mutism syndrome in survivors treated for medulloblastoma. J Neurosurg Pediatr. 2024 Jun 01; 33(6):516-523.
    View in: PubMed
    Score: 0.006
  30. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nat Cancer. 2024 Apr; 5(4):590-600.
    View in: PubMed
    Score: 0.006
  31. Improving Time to Antibiotic Administration for Pediatric Oncology Patients With New-Onset Fever. JCO Oncol Pract. 2024 May; 20(5):725-731.
    View in: PubMed
    Score: 0.006
  32. Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors. Pediatr Blood Cancer. 2024 Apr; 71(4):e30855.
    View in: PubMed
    Score: 0.006
  33. Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma. Int J Radiat Oncol Biol Phys. 2024 May 01; 119(1):200-207.
    View in: PubMed
    Score: 0.006
  34. Neurologic morbidity and functional independence in adult survivors of childhood cancer. Ann Clin Transl Neurol. 2024 02; 11(2):291-301.
    View in: PubMed
    Score: 0.006
  35. Preferences for survivorship education and delivery among Latino and non-Latino childhood cancer survivors and caregivers. J Cancer Surviv. 2025 Apr; 19(2):518-525.
    View in: PubMed
    Score: 0.006
  36. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors. Neuro Oncol. 2023 09 05; 25(9):1698-1708.
    View in: PubMed
    Score: 0.006
  37. The role of surgery in recurrent ependymomas. J Neurosurg Pediatr. 2023 11 01; 32(5):584-589.
    View in: PubMed
    Score: 0.006
  38. Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy. Leuk Res. 2003 Aug; 27(8):743-50.
    View in: PubMed
    Score: 0.006
  39. The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis. Pediatr Blood Cancer. 2023 10; 70(10):e30601.
    View in: PubMed
    Score: 0.006
  40. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol. 2003 Apr 15; 21(8):1602-11.
    View in: PubMed
    Score: 0.006
  41. Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy. J Adolesc Young Adult Oncol. 2023 12; 12(6):828-834.
    View in: PubMed
    Score: 0.006
  42. Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only. J Neurosurg Pediatr. 2023 05 01; 31(5):453-462.
    View in: PubMed
    Score: 0.006
  43. Management of nutritional iron deficiency anemia for young children in the emergency department. Pediatr Blood Cancer. 2023 03; 70(3):e30181.
    View in: PubMed
    Score: 0.006
  44. Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023 Feb; 37(2):204-217.
    View in: PubMed
    Score: 0.006
  45. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017. Cancer Med. 2023 02; 12(3):3644-3656.
    View in: PubMed
    Score: 0.006
  46. Birth weight, ethnicity, and occurrence of cancer in children: a population-based, incident case-control study in the State of Texas, USA. Cancer Causes Control. 2002 Sep; 13(7):595-602.
    View in: PubMed
    Score: 0.006
  47. Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size. Pediatr Blood Cancer. 2022 09; 69(9):e29803.
    View in: PubMed
    Score: 0.005
  48. Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities. Pediatr Neurol. 2022 07; 132:4-10.
    View in: PubMed
    Score: 0.005
  49. Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
    View in: PubMed
    Score: 0.005
  50. Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma. J Cancer Surviv. 2023 08; 17(4):1238-1250.
    View in: PubMed
    Score: 0.005
  51. "Why We Keep Coming Back": Family and Provider Perspectives on Factors Influencing Long-term Follow-up for Pediatric Cancer Survivorship Care. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e176-e184.
    View in: PubMed
    Score: 0.005
  52. Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2022 Jan 15; 128(2):317-325.
    View in: PubMed
    Score: 0.005
  53. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Sci Rep. 2021 10 04; 11(1):19613.
    View in: PubMed
    Score: 0.005
  54. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma. J Neurooncol. 2021 Oct; 155(1):93-100.
    View in: PubMed
    Score: 0.005
  55. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy. Med Pediatr Oncol. 2001 Aug; 37(2):90-6.
    View in: PubMed
    Score: 0.005
  56. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021 Oct 15; 127(20):3865-3871.
    View in: PubMed
    Score: 0.005
  57. Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma. Pediatr Blood Cancer. 2021 10; 68(10):e29178.
    View in: PubMed
    Score: 0.005
  58. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy. Pediatr Blood Cancer. 2021 09; 68(9):e29125.
    View in: PubMed
    Score: 0.005
  59. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):467-481.
    View in: PubMed
    Score: 0.005
  60. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
    View in: PubMed
    Score: 0.005
  61. Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer. 2021 07 01; 127(13):2358-2367.
    View in: PubMed
    Score: 0.005
  62. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
    View in: PubMed
    Score: 0.005
  63. Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.
    View in: PubMed
    Score: 0.005
  64. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer. 2021 01 15; 127(2):310-318.
    View in: PubMed
    Score: 0.005
  65. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med. 2020 11; 22(11):1794-1802.
    View in: PubMed
    Score: 0.005
  66. Reply to S.A. Milgrom et al. J Clin Oncol. 2020 07 01; 38(19):2212-2213.
    View in: PubMed
    Score: 0.005
  67. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
    View in: PubMed
    Score: 0.005
  68. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.005
  69. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
    View in: PubMed
    Score: 0.005
  70. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27952.
    View in: PubMed
    Score: 0.004
  71. Interactions between visual working memory and visual attention among survivors of pediatric acute lymphoblastic leukemia (ALL) and their healthy peers. J Clin Exp Neuropsychol. 2019 11; 41(9):974-986.
    View in: PubMed
    Score: 0.004
  72. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatr Blood Cancer. 2019 09; 66(9):e27800.
    View in: PubMed
    Score: 0.004
  73. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
    View in: PubMed
    Score: 0.004
  74. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma. Cancer Epidemiol. 2019 04; 59:71-74.
    View in: PubMed
    Score: 0.004
  75. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.004
  76. DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Genes Chromosomes Cancer. 2019 01; 58(1):52-59.
    View in: PubMed
    Score: 0.004
  77. Bone marrow transplantation in Shwachman-Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant. 1998 Apr; 21(8):849-51.
    View in: PubMed
    Score: 0.004
  78. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
    View in: PubMed
    Score: 0.004
  79. Alveolar soft part sarcoma in children and young adults: A report of 69 cases. Pediatr Blood Cancer. 2018 05; 65(5):e26953.
    View in: PubMed
    Score: 0.004
  80. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.004
  81. DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors. Neuro Oncol. 2017 Oct 01; 19(10):1372-1379.
    View in: PubMed
    Score: 0.004
  82. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
    View in: PubMed
    Score: 0.004
  83. Predictors of Suboptimal Follow-up in Pediatric Cancer Survivors. J Pediatr Hematol Oncol. 2017 04; 39(3):e143-e149.
    View in: PubMed
    Score: 0.004
  84. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017 Jul 01; 123(13):2570-2578.
    View in: PubMed
    Score: 0.004
  85. Neuroendocrine Tumor of the Appendix in Children. J Pediatr Hematol Oncol. 2017 03; 39(2):97-102.
    View in: PubMed
    Score: 0.004
  86. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016 Nov; 95(46):e5300.
    View in: PubMed
    Score: 0.004
  87. Consensus Report From the Stockholm Pediatric Proton Therapy Conference. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):387-392.
    View in: PubMed
    Score: 0.004
  88. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients. Cancer Epidemiol. 2016 10; 44:161-166.
    View in: PubMed
    Score: 0.004
  89. Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment. J Pediatr Hematol Oncol. 2016 08; 38(6):429-36.
    View in: PubMed
    Score: 0.004
  90. The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 09; 63(9):1557-62.
    View in: PubMed
    Score: 0.004
  91. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.003
  92. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med. 2015 Nov; 4(11):1679-86.
    View in: PubMed
    Score: 0.003
  93. Evaluating the Role of Birth Weight and Gestational Age on Acute Lymphoblastic Leukemia Risk Among Those of Hispanic Ethnicity. Pediatr Hematol Oncol. 2015; 32(6):382-9.
    View in: PubMed
    Score: 0.003
  94. Mucoepidermoid Carcinoma in Children: A Single Institutional Experience. Pediatr Blood Cancer. 2016 Jan; 63(1):27-31.
    View in: PubMed
    Score: 0.003
  95. Birth Characteristics and Childhood Leukemia Risk: Correlations With Genetic Markers. J Pediatr Hematol Oncol. 2015 Jul; 37(5):e301-7.
    View in: PubMed
    Score: 0.003
  96. Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy. Pediatr Cardiol. 2015 Dec; 36(8):1610-6.
    View in: PubMed
    Score: 0.003
  97. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):54-63.
    View in: PubMed
    Score: 0.003
  98. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015 Feb; 114(2):224-9.
    View in: PubMed
    Score: 0.003
  99. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol. 2015 Apr; 28(4):575-86.
    View in: PubMed
    Score: 0.003
  100. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1143-52.
    View in: PubMed
    Score: 0.003
  101. Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Med Inform Decis Mak. 2014 Oct 01; 14:88.
    View in: PubMed
    Score: 0.003
  102. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):354-61.
    View in: PubMed
    Score: 0.003
  103. Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes. Leuk Res. 2014 Sep; 38(9):1055-60.
    View in: PubMed
    Score: 0.003
  104. Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 2015 Jan; 56(1):169-74.
    View in: PubMed
    Score: 0.003
  105. Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Cancer Causes Control. 2014 Jul; 25(7):905-13.
    View in: PubMed
    Score: 0.003
  106. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Clin Cancer Res. 2014 Feb 15; 20(4):904-11.
    View in: PubMed
    Score: 0.003
  107. Do longer formula feeding and later introduction of solids increase risk for pediatric acute lymphoblastic leukemia? Cancer Causes Control. 2014 Jan; 25(1):73-80.
    View in: PubMed
    Score: 0.003
  108. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.003
  109. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
    View in: PubMed
    Score: 0.003
  110. Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2013 May; 37(5):531-5.
    View in: PubMed
    Score: 0.003
  111. Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study. Pediatr Hematol Oncol. 2012 Nov; 29(8):679-85.
    View in: PubMed
    Score: 0.003
  112. A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012 Nov; 23(11):1797-803.
    View in: PubMed
    Score: 0.003
  113. Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol. 2012 Oct; 25(5):305-7.
    View in: PubMed
    Score: 0.003
  114. Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol. 2012 Aug; 14(8):1018-25.
    View in: PubMed
    Score: 0.003
  115. An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer. 2012 Oct; 59(4):605-10.
    View in: PubMed
    Score: 0.003
  116. To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med. 2011 Nov; 13(11):948-55.
    View in: PubMed
    Score: 0.003
  117. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1142-6.
    View in: PubMed
    Score: 0.002
  118. Associations between vaccination and childhood cancers in Texas regions. J Pediatr. 2011 Jun; 158(6):996-1002.
    View in: PubMed
    Score: 0.002
  119. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.002
  120. Elevated expression of CXC chemokines in pediatric osteosarcoma patients. Cancer. 2011 Jan 01; 117(1):207-17.
    View in: PubMed
    Score: 0.002
  121. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 2010 Sep 02; 29(35):4938-46.
    View in: PubMed
    Score: 0.002
  122. Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer. 2010 May 01; 116(9):2242-9.
    View in: PubMed
    Score: 0.002
  123. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.002
  124. Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma. Clin Cancer Res. 2010 Feb 01; 16(3):1049-57.
    View in: PubMed
    Score: 0.002
  125. Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol. 2009 Dec; 11(6):825-32.
    View in: PubMed
    Score: 0.002
  126. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer. 2009 Sep 15; 115(18):4238-45.
    View in: PubMed
    Score: 0.002
  127. Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther. 2009 Aug; 8(8):2461-9.
    View in: PubMed
    Score: 0.002
  128. Primary disseminated intradural malignant peripheral nerve sheath tumor of the spine in a child: case report and review of the literature. Pediatr Neurosurg. 2009; 45(3):230-6.
    View in: PubMed
    Score: 0.002
  129. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr. 2009 Jul; 155(1):73-8.
    View in: PubMed
    Score: 0.002
  130. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2008 Sep; 51(3):387-92.
    View in: PubMed
    Score: 0.002
  131. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol. 2008 Sep 01; 26(25):4138-43.
    View in: PubMed
    Score: 0.002
  132. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):173-7.
    View in: PubMed
    Score: 0.002
  133. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):987-93.
    View in: PubMed
    Score: 0.002
  134. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007 Aug; 161(8):798-806.
    View in: PubMed
    Score: 0.002
  135. Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma. J Pediatr Surg. 2007 Jan; 42(1):148-52.
    View in: PubMed
    Score: 0.002
  136. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006 Apr 01; 24(10):1627-32.
    View in: PubMed
    Score: 0.002
  137. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2005 Dec; 27(12):654-8.
    View in: PubMed
    Score: 0.002
  138. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg. 2004 Oct; 39(10):1506-11.
    View in: PubMed
    Score: 0.002
  139. Molecular epidemiology of glioblastoma. Cancer J. 2003 Mar-Apr; 9(2):99-106.
    View in: PubMed
    Score: 0.001
  140. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg. 2001 Mar; 192(3):305-13.
    View in: PubMed
    Score: 0.001
  141. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia. 1999 Nov; 13(11):1881-92.
    View in: PubMed
    Score: 0.001
  142. Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10. Melanoma Res. 1999 Jun; 9(3):261-72.
    View in: PubMed
    Score: 0.001
  143. Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Clin Cancer Res. 1999 Jan; 5(1):197-202.
    View in: PubMed
    Score: 0.001
  144. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res. 1998 Apr 01; 58(7):1538-43.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.